À la une
Enterome collaborates with BIOASTER Institute to provide new insights into mechanisms of potential microbiome-derived cancer immunotherapies ENTEROME SA, a clinical-stage biopharmaceutical company, and BIOASTER, the French Institute for Technological Research in Infectious Diseases and Microbiology, today announced they have entered into a research collaboration. The complete press release here.
BIOASTER proud to be part of the 14-partner 10-million€ consortium to identify novel biomarkers and therapeutic targets needed for future precision medicine approaches against sepsis
Launch of EU Research Project ImmunoSep: Advancing Personalised Immunotherapy in Sepsis Multinational consortium aims to identify novel biomarkers, and therapeutic targets needed for future precis...